Johnson & Johnson Newsroom

Is Johnson & Johnson (NYSE:JNJ) a Cheap NYSE Stock to Invest in According to Hedge Funds?

Yahoo FinanceApr 12 09:05 ET

Guggenheim Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $166

Moomoo NewsApr 11 19:31 ET · Ratings

Unusual Options Activity: LEVI, PDD and Others Attract Market Bets, LEVI V/OI Ratio Reaches 1323.5

Moomoo NewsApr 11 16:30 ET

Wolfe Research Cuts Johnson & Johnson Price Target to $175 From $190

MT NewswiresApr 11 13:13 ET · Ratings

Today's Analyst Rating | Wedbush Cuts Its Price Target Cut on Microsoft to $475, Citi Cuts Its Price Target Cut on NVIDIA to $150

Moomoo NewsApr 11 08:00 ET · Ratings

AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."

① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.

cls.cnApr 11 07:59 ET

BofA Securities Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Cuts Target Price to $159

Moomoo NewsApr 10 18:31 ET · Ratings

Kenvue Stock Could Be a Cure for Investors' Headaches -- Barrons.com

Barron'sApr 10 14:48 ET

Novartis Is Reportedly Eyeing $23B Investment in U.S.

Seeking AlphaApr 10 14:03 ET

Johnson & Johnson Reports Promising Results From Skin Disease Trial

Seeking AlphaApr 10 10:32 ET

Alphabet To $185? Here Are 10 Top Analyst Forecasts For Thursday

BenzingaApr 10 09:24 ET

Johnson & Johnson Is Maintained at Neutral by B of A Securities

Dow JonesApr 10 08:41 ET · Ratings

Johnson & Johnson Analyst Ratings

BenzingaApr 10 08:30 ET · Ratings

Johnson & Johnson Presents Icotrokinra Results Showing 75% Of Adolescents With Plaque Psoriasis Achieved Completely Clear Skin And Demonstrate Favorable Safety Profile In A Once Daily Pill

BenzingaApr 10 08:08 ET

Express News | Johnson & Johnson - 84% of Adolescents Achieved Clear or Almost Clear Skin at Week 16

ReutersApr 10 08:05 ET

Express News | Johnson & Johnson - Icotrokinra Shows Favorable Safety Profile With 50% Experiencing ≥1 Ae

ReutersApr 10 08:05 ET

Express News | J&J : BofA Global Research Cuts Price Objective to $159 From $171

ReutersApr 10 07:15 ET

Icotrokinra Results Show 75% of Adolescents With Plaque Psoriasis Achieved Completely Clear Skin and Demonstrate Favorable Safety Profile in a Once Daily Pill

Johnson & JohnsonApr 10 00:00 ET

Earnings Preview: JNJ to Report Financial Results Pre-market on April 15

Moomoo NewsApr 9 21:00 ET

Goldman Sachs Initiates Johnson & Johnson(JNJ.US) With Buy Rating, Announces Target Price $172

Moomoo NewsApr 9 19:33 ET · Ratings